The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II

Por Smits, Anja, Baumert, Brigitta G.
Publicado em 2011

Follow-up assessment of vestibular schwannomas: volume quantification versus two-dimensional measurements

Por van de Langenberg, Rick, de Bondt, Bert Jan, Nelemans, Patty J., Baumert, Brigitta G., Stokroos, Robert J.
Publicado em 2009

An Individual Patient Data Meta-Analysis on Characteristics, Treatments and Outcomes of Glioblastoma/ Gliosarcoma Patients with Metastases Outside of the Central Nervous System

Por Pietschmann, Sophie, von Bueren, André O., Kerber, Michael J., Baumert, Brigitta G., Kortmann, Rolf Dieter, Müller, Klaus
Publicado no PLoS One (2015)

Case Report: Pulmonary metastases of malignant meningioma

Por Basunaid, Suhail, Franssen, Frits M.E., Accord, Ryan, Hamid, Myrurgia Abdul, Mahesh, Shekar, Baumert, Brigitta G., Schijns, Olaf E.M.G.
Publicado em 2014

F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review

Por Schröer-Günther, Milly A, Wolff, Robert F, Westwood, Marie E, Scheibler, Fülöp J, Schürmann, Christoph, Baumert, Brigitta G, Sauerland, Stefan, Kleijnen, Jos
Publicado em 2012

Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group

Por Müller, Klaus, Scheithauer, Heike, Pietschmann, Sophie, Hoffmann, Marion, Rössler, Jochen, Graf, Norbert, Baumert, Brigitta G, Christiansen, Hans, Kortmann, Rolf-Dieter, Kramm, Christof M, von Bueren, André O
Publicado no Radiat Oncol (2014)

The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures

Por Narayan, Ravi S., Fedrigo, Carlos A., Brands, Eelke, Dik, Rogier, Stalpers, Lukas J.A., Baumert, Brigitta G., Slotman, Ben J., Westerman, Bart A., Peters, Godefridus J., Sminia, Peter
Publicado no BMC Cancer (2017)

New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III...

Por Gorlia, Thierry, Wu, Wenting, Wang, Meihua, Baumert, Brigitta G., Mehta, Minesh, Buckner, Jan C., Shaw, Edward, Brown, Paul, Stupp, Roger, Galanis, Evanthia, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2013

Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1)

Por Oehlke, Oliver, Mix, Michael, Graf, Erika, Schimek-Jasch, Tanja, Nestle, Ursula, Götz, Irina, Schneider-Fuchs, Sabine, Weyerbrock, Astrid, Mader, Irina, Baumert, Brigitta G., Short, Susan C., Meyer, Philipp T., Weber, Wolfgang A., Grosu, Anca-Ligia
Publicado no BMC Cancer (2016)

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

Por Kocher, Martin, Soffietti, Riccardo, Abacioglu, Ufuk, Villà, Salvador, Fauchon, Francois, Baumert, Brigitta G., Fariselli, Laura, Tzuk-Shina, Tzahala, Kortmann, Rolf-Dieter, Carrie, Christian, Hassel, Mohamed Ben, Kouri, Mauri, Valeinis, Egils, van den Berge, Dirk, Collette, Sandra, Collette, Laurence, Mueller, Rolf-Peter
Publicado em 2011

The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network

Por Baumert, Brigitta G, Spahr, Martin O, Hochstetter, Arthur Von, Beauvois, Sylvie, Landmann, Christine, Fridrich, Katrin, Villà, Salvador, Kirschner, Michael J, Storme, Guy, Thum, Peter, Streuli, Hans K, Lombriser, Norbert, Maurer, Robert, Ries, Gerhard, Bleher, Ernst-Arnold, Willi, Alfred, Allemann, Juerg, Buehler, Ulrich, Blessing, Hugo, Luetolf, Urs M, Davis, J Bernard, Seifert, Burkhardt, Infanger, Manfred
Publicado em 2007

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma: A randomized phase III Intergroup study by EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033)

Por Baumert, Brigitta G., Hegi, Monika E., van den Bent, Martin J., von Deimling, Andreas, Gorlia, Thierry, Hoang-Xuan, Khê, Brandes, Alba A., Kantor, Guy, Taphoorn, Martin J.B., Hassel, Mohamed Ben, Hartmann, Christian, Ryan, Gail, Capper, David, Kros, Johan M., Kurscheid, Sebastian, Wick, Wolfgang, Enting, Roelien, Reni, Michele, Thiessen, Brian, Dhermain, Frederic, Bromberg, Jacoline E., Feuvret, Loic, Reijneveld, Jaap C., Chinot, Olivier, Gijtenbeek, Johanna M. M., Rossiter, John P., Dif, Nicolas, Balana, Carmen, Bravo-Marques, Jose, Clement, Paul M., Marosi, Christine, Tzuk-Shina, Tzahala, Nordal, Robert A., Rees, Jeremy, Lacombe, Denis, Mason, Warren P., Stupp, Roger
Publicado no Lancet Oncol (2016)